In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Bristol-Myers Squibb stock has fallen by 35% in the last six months.
Doug Kass shares his thoughts on buying retail, and discusses why he's favoring the short side in a big way.
Doug Kass shares his thoughts on biotech and discusses the shape of things to come.
Here's how to trade seven of the most active stocks on the market this week.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.